High-Intensity Laser Therapy (HILT) for Pain

Mechanism of Action

HILT's biological effect results from a specific combination of mechanisms that distinguishes it from both LLLT and other physical energy modalities. The main differentiator is the photomechanical effect — particularly expressive in HILT due to the high-power pulsed emission. Rapid absorption of laser pulses in tissue generates acoustic pressure waves that propagate in depth, producing controlled mechanical stimulus on structures that would be out of reach of traditional LLLT. This mechanical component is what explains the relatively rapid analgesic response observed in clinical applications.

Added to the mechanical component, there is the photochemical effect — shared with LLLT, but on a larger scale due to the total dose delivered in HILT. The photonic energy is absorbed primarily by cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain. This interaction increases the production of ATP, transiently releases nitric oxide (NO) and reactive oxygen species (ROS) at concentrations that function as secondary messengers — signaling that modulates cell proliferation, matrix synthesis, and local regenerative response.

A third component is the modulation of inflammatory cytokines: in vitro and animal model studies document reduction of IL-6, TNF-alpha, and PGE2 in tissues irradiated with parameters compatible with HILT. This anti-inflammatory signaling contributes to reducing pain and edema in chronic inflammatory conditions such as osteoarthritis in flare phase.

There is, finally, a component of local neuromodulation: inhibition of nociceptive C fibers and hyperpolarization of neural membranes in the irradiated territory, a mechanism that reinforces the direct analgesic effect. The combination of these four elements — photomechanical, photochemical, anti-inflammatory, and neuromodulatory — is what defines the therapeutic profile of HILT. Each isolated element has modest magnitude; the relevant clinical benefit depends on the sum of effects, which explains why HILT works better in structured protocols with adequate total dose than in isolated low-dose applications.

Evidence by Condition

Scientific evidence for HILT is heterogeneous — robust in some musculoskeletal indications, limited or uncertain in others. An honest reading of the literature requires distinguishing conditions in which the technique has meta-analyses with clinically relevant effects from those where support is weak. International guidelines on pain management and osteoarthritis, when they mention HILT, position it as an adjuvant option, not as a first-line modality.

In knee osteoarthritis, HILT meta-analyses (including Song et al., 2021) aggregated RCTs of moderate quality and documented moderate effect on pain (VAS) and function (WOMAC) compared with placebo or standard treatment. The magnitude of benefit, expressed as standardized mean difference (SMD) around 0.5-0.8 in 4-12 week follow-up, is clinically relevant — the conversion of this magnitude into "percentage" of reduction depends on baseline and may vary substantially among studies. Similar results were observed in Kheshie et al. (2014), who compared HILT to LLLT in knee OA and found superiority of HILT in some functional outcomes — a relevant finding, though preliminary.

In frozen shoulder (adhesive capsulitis) in the chronic phase, Santamato et al. demonstrated in a controlled RCT significant reduction of pain and gain of range of motion with a HILT protocol associated with kinesiotherapy, compared with isolated kinesiotherapy. In rotator cuff tendinopathy, small RCTs show moderate benefit when HILT is associated with structured therapeutic exercise, particularly in chronic refractory cases.

In diffuse myofascial pain, fibromyalgia, and other generalized pain syndromes, the evidence is scarce and of low quality — there is no clear recommendation in favor of HILT in this group. Small studies suggest symptomatic improvement in subgroups, but the heterogeneity of protocols and the absence of adequate control groups compromise interpretation.

An essential point: the NICE (2022) and OARSI (2019) guidelines do not list HILT as first line in osteoarthritis. The first line in these guidelines remains structured therapeutic exercise, weight control, and stepped pharmacologic analgesia. HILT is recognized as an adjuvant option in refractory cases or as part of a combined approach, not as isolated therapy or first choice.

HILT vs LLLT — comparative table

Since HILT and LLLT are frequently confused — and the clinical choice between them depends on understanding the technical differences — the table below summarizes the main distinguishing parameters. HILT and LLLT are not "stronger" and "weaker" versions of the same technology: they are modalities with different predominant mechanisms, distinct targets, and partially overlapping indications.

In clinical practice, the choice between the two modalities depends on the depth of the target and the type of effect desired. For superficial conditions (skin lesions, superficial tendinopathies, focal superficial myofascial pain), LLLT is sufficient and cheaper. For deep articular or tendinous conditions (knee osteoarthritis, frozen shoulder, rotator cuff tendinopathy), HILT has the advantage of delivering energy to deep planes with a photomechanical component that LLLT cannot reproduce.

Indications

HILT indications are defined by two main variables: condition with acceptable evidence (knee OA, chronic frozen shoulder, chronic rotator cuff tendinopathy) and failure of first-line conservative treatment (structured exercise, load control, pertinent pharmacologic management). HILT is not first-line modality in any of the conditions below — it occupies an adjuvant or second-line position after attempting modalities with more consolidated evidence.

How It Is Done and What to Expect

The HILT session is performed in an office or physical medicine clinic, with the patient positioned to comfortably expose the treatment área. Both the operator and the patient wear protective glasses specific to the wavelength — a mandatory and non-negotiable item: accidental retinal exposure to the 1064 nm beam can cause permanent ocular damage.

The typical parameters per session vary according to condition and tissue: total energy of 2000 to 5000 J per session, energy density between 50 and 200 J/cm2, fluence adjusted according to target depth and tissue sensitivity. In joints with thick capsule (shoulder, hip) and in deep tissues, higher densities are used; in superficial tendinopathies or more sensitive skin, intermediate doses. Application is manual — the applicator is moved in continuous sweeping over the target área, avoiding remaining over the same point só as not to concentrate the thermal effect.

Each session lasts on average 10 to 15 minutes. The patient perceives warmth in the treated region — progressive thermal sensation, well tolerated at the correct dose and not painful when dosimetry is adequate. If the patient reports acute pain during application, this indicates that the dose is excessive or that the applicator remained too long at a single point; the conduct is to reduce power or increase sweeping speed. The standard protocol contemplates 8 to 12 sessions, with frequency of 2 to 3 times a week, and structured clinical reassessment after each block of 6 to 8 sessions.

An essential operational point: HILT does not replace active rehabilitation. The most consistent clinical gain documented in RCTs occurs when the technique is part of a plan that includes prescribed exercise (strengthening, mobility, load reeducation). Applied in isolation, without an associated rehabilitation program, HILT produces less benefit and with greater risk of recurrence after the end of the series of sessions.

HILT application on a knee with osteoarthritis: operator and patient wear protective glasses; the applicator moves continuously over the medial compartment

Fig. · placeholder

Adverse Effects, Risks, and Contraindications

HILT presents a favorable safety profile when applied by a trained operator with adequate dosimetry, with very rare serious adverse events. However, the technique delivers energy sufficient to cause tissue and ocular injury under conditions of incorrect exposure or absence of protection — absolute contraindications and operational precautions must be rigorously respected.

About ocular protection: the 1064 nm Nd:YAG laser is invisible to the human eye and has high penetration in transparent ocular média. An accidental direct exposure or by reflex on a metallic surface can cause permanent retinal injury, without immediate pain at the moment of exposure. The rule is simple and non-negotiable: operator and patient wear protective glasses certified for the wavelength throughout the session, without exception. Environments with HILT in operation must have safety signage and access control — it is not acceptable to perform the technique in a room with people passing through without protection.

About dark skin and hyperpigmentation: in skin types V and VI (Fitzpatrick scale), the greater concentration of melanin increases superficial thermal absorption. In a protocol with excessive density or stationary applicator, residual hyperpigmentation may occur. Prevention is operational: density reduction, increased sweeping speed, and avoidance of excessive overlap on the same point.

Limitations and What Is Not Yet Known

HILT is a useful therapeutic tool for specific indications, but it faces significant methodological and practical limitations that must be communicated honestly to the patient before deciding to start a series.

Central Gaps

Optimal parameters not consensual among manufacturers. Total dose, energy density, pulse frequency, and interval between sessions vary significantly across equipment and centers. The same "HILT technology" can yield different clinical outcomes depending on the protocol used, which makes both replication of positive studies and consolidation of specific guidelines difficult. Current meta-analyses are compromised by this heterogeneity.

High cost and restricted availability. HILT equipment (class IV Nd:YAG laser) carries high acquisition and maintenance costs, and the technique is concentrated in clinics specializing in physical medicine, orthopedics, and sports medicine in the private network. In public health systems, availability is typically very rare — restricted to a few university centers. In private insurance, coverage depends on the operator and frequently requires prior authorization.

Heterogeneity of RCTs compromises interpretation. The HILT literature includes studies of variable methodological quality, with small samples, inconsistent blinding, and short follow-up. This limits the strength of recommendations and explains why international guidelines position the technique as adjuvant — not from contrary evidence, but from evidence still insufficiently robust to support first-line use.

Few studies on long-term outcomes. Most RCTs evaluate response at 4 to 12 weeks. Data on sustained effect at 6 months, 1 year, or longer are scarce, making it difficult to honestly gauge the need for maintenance and the long-term cost-effectiveness of the technique.

Relationship to Medical Acupuncture

HILT and medical acupuncture act through fundamentally different mechanisms and, for that reason, can be complementary in a structured treatment plan. HILT operates on the photomechanical and photochemical plane, modulating tissue in depth by energy absorption. Medical acupuncture operates on the neuromodulatory plane: activation of afferent pathways, release of endogenous opioids, descending inhibitory modulation, and neurogenic anti-inflammatory effects. They are distinct biological targets.

In practice, this means the two techniques are not interchangeable — and, in many cases, work better combined than alone. In knee osteoarthritis, for example, medical acupuncture has moderate-to-high evidence in guidelines such as NICE 2021 for management of primary and secondary chronic pain, with a benefit profile similar to HILT in some outcomes and with cost and availability clearly more favorable in the Brazilian context. In myofascial pain and chronic low back pain, acupuncture is clearly superior to HILT in terms of evidence.

HILT and acupuncture can be combined in the same plan, acting on distinct biological planes: HILT modulating the local structural and inflammatory component, acupuncture modulating the neural and central component. A specific scenario with dedicated literature is the combination of therapeutic laser with electroacupuncture, particularly in peripheral neuropathies and chronic articular pain — see our dedicated article on laser + electroacupuncture for the discussion of combined protocols and specific evidence. In clinical practice, the decision to combine, sequence, or alternate the modalities should be based on structured medical evaluation and an individualized plan.

When to Seek Medical Care

The decision to evaluate HILT starts with a structured medical consultation — including diagnostic characterization of the pain and review of prior conservative treatment. Seeking the technique without a clear indication or an associated rehabilitation plan tends to result in frustration and cost without proportional benefit.